Two More Manufacturing Sites For BioNtech/Pfizer Covid Vaccine Approved.

They're in Switzerland and Germany.

Two more manufacturing sites have been approved by European health regulators for the BioNtech/Pfizer Covid vaccine.

The sites in Germany and Switzerland are expected to support the continued supply of the vaccine in the European Union.

According to the EMA, the sites can become operational immediately.
 

EMA has approved additional manufacturing sites for the production of Comirnaty, the #COVID19vaccine developed by BioNTech and Pfizer. https://t.co/kFXSVB6rRn#VaccinesWork #CovidVaccines pic.twitter.com/sKSBaBkrzu

— EU Medicines Agency (@EMA_News) June 22, 2021